ClinicalyesterdayNew
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor - drugdiscoverytrends.com
By Julia Rock-Torcivia | August 31, 2026 A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient’s tumor, designed to teach their immune system to recognize the cancer as a foreign body. The companies are investi…